IABP Intra-aortic balloon pump

DEVICE3 trials

Sponsors

Abiomed Inc., magAssist, Inc.

Conditions

Coronary Artery DiseaseHigh-Risk PCILeft Ventricular Dysfunction

Phase 3

Protect II, A Prospective, Multicenter Randomized Controlled Trial

TerminatedNCT00562016

Abiomed Inc.Coronary Artery Disease

Start: 2007-10-31End: 2011-09-30Updated: 2011-03-21

Unknown Phase

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Active, not recruitingNCT04763200

Abiomed Inc.Coronary Artery Disease, Left Ventricular Dysfunction

Start: 2021-04-13End: 2027-10-01Target: 1252Updated: 2026-07-28

SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI

Active, not recruitingNCT07010965

magAssist, Inc.High-Risk PCI

Start: 2024-07-31End: 2026-01-31Updated: 2026-01-12

Related Papers

Characteristics and Outcomes of Older Patients Undergoing Protected Percutaneous Coronary Intervention With Impella

Journal of the American Heart Association2025-04-172 citations

Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Circulation Cardiovascular Interventions2024-05-064 citations

Predictors of left ventricular ejection fraction in high-risk percutaneous coronary interventions

Frontiers in Cardiovascular Medicine2024-02-023 citations

Revascularisation for Ischaemic Cardiomyopathy.

2023-08-016 citations

Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.

2022-04-1857 citations

Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.

2015-08-1550 citations

A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

2012-08-30583 citations